Immunic Therapeuticsalso Known As Immunicinc Is A Clinical Stage Biopharmaceutical Company Based In New York Citythe Company Specializes In Developing Innovative Oral Therapies For Chronic Inflammatory And Autoimmune Diseasesits Research And Development Activities Are Conducted By Its Subsidiaryimmunic Aglocated In Gra Felfinggermany Immunic Is Focused On Creating Best In Class Oral Therapieswith A Pipeline That Includes Key Products Such As Imu 838A Selective Immune Modulator For Conditions Like Ulcerative Colitis And Crohnae S Diseaseimu 935Which Regulates Immune Responsesand Imu 856Aimed At Restoring Intestinal Barrier Functionthe Company Is Publicly Traded On The Nasdaq Under The Ticker Symbolimux Reflecting Its Commitment To Transparency And Financial Accountability In The Biotech Industry
